| Autor: |
Vrankar Martina, Stanic Karmen, Jelercic Stasa, Ciric Eva, Vodusek Ana Lina, But-Hadzic Jasna |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Radiology and Oncology, Vol 55, Iss 4, Pp 482-490 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
1581-3207 |
| DOI: |
10.2478/raon-2021-0044 |
| Popis: |
Chemoradiotherapy (ChT-RT) followed by 12-month durvalumab is the new standard treatment for unresectable stage III non-small cell lung cancer. Survival data for patients from everyday routine clinical practice is scarce, as well as potential impact on treatment efficacy of sequential or concomitant chemotherapy and the usage of gemcitabine. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
